Rain Therapeutics Inc. is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. Rain’s lead product candidate, RAIN-32 (milademetan, formerly known as DS-3032), is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to RAIN-32, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.
| Market Cap | 440.936 Million | Shares Outstanding | 26.483 Million | Avg 30-day Volume | 92.253 Thousand | ||
| P/E Ratio | Dividend Yield | EPS | |||||
| Price/Sales | Debt to Equity | EBITDA | |||||
| Price to Book Value | 0.0 | Forward PE | -0.91 | Enterprise Value | |||
| Total Cash | Current Debt | Gross Profit | |||||
| BETA | 0.0 | 52-week High/Low | 23.9 / 14.08 | Next Earnings Date | 2021-08-25 | Price to Cash FLow (P/CF) | -9999999.0 |
| Data provided by IEX Cloud | |||||||
| Q1 2021 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|---|---|---|---|---|---|
| No data found for this quarter. | ||||||
| 1 hedge funds and active managers as identified by whalewisdom.com through public filings. | ||||||
Please sign in first
587 Thousand total shares from 6 transactions
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
BIOTECHNOLOGY VALUE FUND II LP |
|
7,962,851 | 2021-07-01 | 7 |
|
24,000 | 2021-05-14 | 2 | |
|
24,000 | 2021-05-14 | 1 | |
|
CABATUAN NELSON SEE REMARKS |
|
6,000 | 2021-05-12 | 1 |
|
VELLANKI AVANISH PRESIDENT AND CEO |
|
2,511,442 | 2021-04-27 | 1 |
|
DOEBELE ROBERT EVP, CHIEF SCIENTIFIC OFFICER |
|
467,937 | 2021-04-27 | 1 |
|
8,796 | 2021-04-27 | 1 | |
|
2,537,019 | 2021-04-27 | 1 | |
|
CORMORANT ASSET MANAGEMENT, LP CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP |
|
No longer subject to file | 2021-04-27 | 1 |
|
4,277,215 | 2021-04-23 | 1 | |
|
4,277,215 | 2021-04-23 | 1 |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 22:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 21:45:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 21:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 20:45:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 20:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 19:45:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 19:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 18:45:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 18:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 17:45:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 17:15:03 UTC | -2.0373 | 2.0973 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 16:45:03 UTC | -2.0389 | 2.1189 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 16:15:03 UTC | -2.0389 | 2.1189 | 3000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 15:45:03 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 15:15:03 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 14:45:03 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 14:15:03 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 13:45:03 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 13:15:04 UTC | -2.0389 | 2.1189 | 2000 |
| RAIN THERAPEUTICS INC RAIN | 2021-08-02 12:45:03 UTC | -2.0389 | 2.1189 | 2000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
